A worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 60 independent distributors into over 100 countries.
Type
Public
HQ
Mountain View, US
Founded
1989
Size (employees)
108 (est)
Website
iridex.com
IRIDEX was founded in 1989 and is headquartered in Mountain View, US

IRIDEX Office Locations

IRIDEX has an office in Mountain View
Mountain View, US (HQ)
1212 Terra Bella Ave

IRIDEX Metrics

IRIDEX Financial Metrics

Revenue (2016)

$46.2 m

Revenue growth (2015-16), %

11%

Gross profit

$20.8 m

Gross profit margin (2016), %

45%

Net income (2016)

($11.7 m)

Market capitalization (21-Mar-2017)

$139 m

Closing share price (21-Mar-2017)

$14

Cash (31-Dec-2016)

$23.7 m
IRIDEX's current market capitalization is $139 m.
IRIDEX's revenue was reported to be $46.2 m in FY, 2016 which is a 10.5% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$38.3 m$42.8 m$41.8 m$46.2 m

Revenue growth, %

12%(2%)11%

Cost of goods sold

$19.7 m$21.4 m$21.8 m$25.3 m

Gross profit

$18.6 m$21.4 m$20 m$20.8 m

Gross profit Margin, %

49%50%48%45%

Sales and marketing expense

$7.7 m$8.2 m$8.9 m$10.3 m

R&D expense

$3.7 m$4.6 m$5.2 m$5.4 m

General and administrative expense

$5 m$6 m$5.6 m$7.6 m

Operating expense total

$16 m$18.8 m$19.7 m$23.4 m

EBIT

$288 k($2.6 m)

EBIT margin, %

1%(6%)

Income tax expense

$31 k($8.7 m)($183 k)$9.1 m

Net Income

$2.2 m$10 m$474 k($11.7 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$13.4 m$13.3 m$10 m$23.7 m

Inventories

$32.4 m$84 m$98.4 m

Current Assets

$32 m$32.9 m$30.8 m$45.9 m

PP&E

$543 k$735 k$1.1 m$1.5 m

Goodwill

$533 k$533 k$533 k$533 k

Total Assets

$33.7 m$41.8 m$41.8 m$48.1 m

Accounts Payable

$19.7 m$39.6 m$76.9 m

Current Liabilities

$7.4 m$7 m$7.4 m$8.5 m

Additional Paid-in Capital

$40.7 m$38.5 m$38 m$55.2 m

Retained Earnings

($14.9 m)($4.9 m)($4.4 m)($16.1 m)

Total Equity

$33.7 m$39.2 m

Financial Leverage

1.2 x1.2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$2.2 m$10 m$474 k($11.7 m)

Depreciation and Amortization

$490 k$420 k$522 k$648 k

Accounts Payable

$24.9 m($21.9 m)

Cash From Operating Activities

$767 k$4 m($593 k)

Purchases of PP&E

($380 k)($568 k)($875 k)($1.1 m)

Cash From Investing Activities

($763 k)($1 m)($1.3 m)($1.5 m)

Cash From Financing Activities

$1 m($3.1 m)($1.4 m)$15.4 m

Income Taxes Paid

($536 k)$35 k$27 k$22 k

IRIDEX Market Value History

IRIDEX Online Presence

IRIDEX Company Life

You may also be interested in